Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
3.760
-0.040 (-1.05%)
At close: May 12, 2025, 4:00 PM
4.020
+0.260 (6.91%)
After-hours: May 12, 2025, 7:20 PM EDT

Eupraxia Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-25.5-28.22-18.49-18.93-3.14
Upgrade
Depreciation & Amortization
0.170.160.150.090.09
Upgrade
Loss (Gain) From Sale of Assets
-0.0200.01-0.1
Upgrade
Stock-Based Compensation
3.221.411.432.710.18
Upgrade
Other Operating Activities
-1.10.550.994.721.2
Upgrade
Change in Accounts Receivable
-0.1-0.10.230.150.57
Upgrade
Change in Accounts Payable
-0.710.581.32-0.50.67
Upgrade
Change in Other Net Operating Assets
-5.954.88-0.040.050
Upgrade
Operating Cash Flow
-29.99-20.75-14.4-11.72-0.32
Upgrade
Capital Expenditures
-0.1-0.07-0.24-0.34-
Upgrade
Sale of Property, Plant & Equipment
0.03-0-0.06
Upgrade
Investment in Securities
--10.07-7.11-
Upgrade
Other Investing Activities
----3.97-0.04
Upgrade
Investing Cash Flow
-0.08-0.079.83-11.420.02
Upgrade
Short-Term Debt Issued
---0.080.56
Upgrade
Long-Term Debt Issued
---10.08-
Upgrade
Total Debt Issued
---10.160.56
Upgrade
Long-Term Debt Repaid
-9.14-0.08-0.14-0.46-0.86
Upgrade
Net Debt Issued (Repaid)
-9.14-0.08-0.149.69-0.31
Upgrade
Issuance of Common Stock
54.9221.1610.9429.9-
Upgrade
Other Financing Activities
-----0.19
Upgrade
Financing Cash Flow
45.7821.0810.839.59-0.49
Upgrade
Foreign Exchange Rate Adjustments
-1.960.82-0.51-0.06-0
Upgrade
Net Cash Flow
13.761.085.7316.39-0.79
Upgrade
Free Cash Flow
-30.1-20.82-14.63-12.06-0.32
Upgrade
Free Cash Flow Per Share
-0.89-0.86-0.76-0.97-0.05
Upgrade
Cash Interest Paid
0.390.60.330.460.09
Upgrade
Levered Free Cash Flow
-20.95-10.78-8.72-12.98-0.59
Upgrade
Unlevered Free Cash Flow
-20.35-10.05-8.11-12.370.34
Upgrade
Change in Net Working Capital
6.76-5.86-1.565.98-1.17
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q